JG

Julie Grant

General Partner at Canaan

San Francisco Bay Area

Overview

Work Experience

C

Canaan

  • General Partner

    2019 - Current

  • Partner

    2016 - 2019

  • Principal

    2014 - 2016

  • Associate

    2013 - 2014

S

Synthekine

  • Board Member

    2019

DO

Day One Biopharmaceuticals

  • Chair Of The Board Of Directors

    2020 - 2023

  • Co-Founder and Chief Executive Officer

    2018 - 2020

G

Glooko

  • Board Observer

    2015 - 2019

BC

Biden Cancer Initiative

  • Board Member

    2017 - 2018

Chrono Therapeutics

  • Board Observer

    2014 - 2018

PT

Protagonist Therapeutics

  • Board Member

    2015 - 2017

CT

CytomX Therapeutics

  • Board Observer

    2013 - 2015

CR

Cellular Research

  • Seed Investor and Board Observer

    2013 - 2015

Education

Investments

Synthekine

Series A

Total Funding: $290M

Day One Biopharmaceuticals

Series A

Total Funding: $370M

Protagonist Therapeutics

Series C

Total Funding: $54M

Relevant Websites